MoonLake Immunotherapeutics (MLTX) Stock Price
$38.33 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
0 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MoonLake Immunotherapeutics, AI stock picks, stock alerts and much more.
MLTX AI Stock Analysis
AI stock analysis for MLTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MoonLake Immunotherapeutics (MLTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MoonLake Immunotherapeutics (MLTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MoonLake Immunotherapeutics (MLTX), currently trading at $38.33, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MLTX
-
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.
-
Symbol
MLTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.4B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
MLTX Alternative Data
Web Traffic
MoonLake Immunotherapeutics receives an estimated 4765 monthly visitors to moonlaketx.com.
-
Web Traffic
4765
-
Change from Previous Month
10%
-
3 Month Change
29.5%
-
YoY Change
29.5%
News Mentions
MoonLake Immunotherapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
MoonLake Immunotherapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Followers
6,145 are following MoonLake Immunotherapeutics on LinkedIn, up by 5.8% over the last month.
-
LinkedIn Followers
6145
-
Daily Change
0%
-
1 Month Change
5.8%
-
3 Month Change
19.2%
Job Postings
MoonLake Immunotherapeutics currenly has an estimated 8 open job postings, up by 33.3% over the last month.
-
Job Postings
8
-
Daily Change
0%
-
1 Month Change
33.3%
-
3 Month Change
14.3%
-
YoY Change
14.3%
Twitter Followers
MoonLake Immunotherapeutics has 108 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
108
-
Daily Change
0.9%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, MoonLake Immunotherapeutics has 111 employees.
-
LinkedIn Employees
111
-
Daily Change
0.9%
-
1 Month Change
0%
-
3 Month Change
6.7%
-
YoY Change
6.7%
MLTX Financials
MLTX Key Metrics
-
Total Revenue
$101.9K
-
Net Income
-$45.6M
-
Earnings per Share
$1.16
-
Free cash flow
-$117B
-
EBITDA
-$48.3M
-
EBITDA Ratio
-474.021
-
Total Assets
$477.9B
MLTX 2-year Revenue & Income
MLTX 2-year Free Cash Flow
MLTX Technicals
MLTX SMA
MLTX RSI
FAQ
What's the current price of MoonLake Immunotherapeutics (MLTX) Stock?
The price of an MoonLake Immunotherapeutics (MLTX) share is $38.33.
What's the market cap of MoonLake Immunotherapeutics?
The current market cap of MoonLake Immunotherapeutics is 2.4B.
Should I buy or sell MLTX?
MoonLake Immunotherapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is MoonLake Immunotherapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in MoonLake Immunotherapeutics stock. There are several bearish signals and market challenges that could negatively impact MoonLake Immunotherapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy MoonLake Immunotherapeutics (MLTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy MoonLake Immunotherapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to MoonLake Immunotherapeutics (MLTX) that investors often compare it to?
MoonLake Immunotherapeutics (MLTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for MoonLake Immunotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MoonLake Immunotherapeutics' stock price to be around $35.51 in 2026. Starting from the current price of $38.33, this represents a 7.3% change in price, indicating a bearish outlook for the stock.
How to buy MoonLake Immunotherapeutics (MLTX) Stock?
MoonLake Immunotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MoonLake Immunotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.